EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection

Xuewen Li, Yiting Wang, Junqi Pan, Jiancheng Xu iD, Qi Zhou

Laboratory Medicine · 2023

DOI: 10.1093/labmed/lmac089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Xuewen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: COVID-19, Nucleic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 is a serious threat to human life, and early diagnosis and screening can help control the COVID-19 pandemic. The high sensitivity of reverse transcriptase–polymerase chain reaction (RT-PCR) assay is the gold standard for the diagnosis of COVID-19, but there are still some false-negative results. Rapid antigen detection (RAD) is recommended by the World Health Organization (WHO) as a screening method for COVID-19. This review analyzed the characteristics of RDT and found that although the overall sensitivity of RAD was not as high as that of RT-PCR, but RAD was more sensitive in COVID-19 patients within 5 days of the onset of symptoms and in COVID-19 patients with Ct ≤ 25. Therefore, RAD can be used as an adjunct to RT-PCR for screening patients with early COVID-19. Finally, this review provides a combined diagnostic protocol for RAD and nucleic acid testing with the aim of providing a feasible approach for COVID-19 screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nucleic AcidsHumansSARS-CoV-2COVID-19 TestingPandemicsClinical Laboratory TechniquesSensitivity and Specificity

Stichwörter der Autor:innen

COVID-19Early screeningLateral flow immunoassayRT-PCRSensitivity

Substanzen

Nucleic Acids

Autor:innen und Institutionen

  • Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, China.
  • Bachelor of Biomedicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Pediatrics, First Hospital of Jilin University, Changchun, China.

ORCID-Profile: Jiancheng Xu

Zitieren

APA

Li, X., Wang, Y., Pan, J., Xu, J., & Zhou, Q. (2023). Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac089

Vancouver

Li X, Wang Y, Pan J, Xu J, Zhou Q. Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac089

BibTeX
@article{Li2023,
  author = {Li, Xuewen and Wang, Yiting and Pan, Junqi and Xu, Jiancheng and Zhou, Qi},
  title = {Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection},
  journal = {Laboratory Medicine},
  year = {2023},
  doi = {10.1093/labmed/lmac089}
}
Kostenlos starten →